Search
+
    SEARCHED FOR:

    THE DRUG CONTROLLER GENERAL OF INDIA

    Miguel Angel Felix Gallardo, architect of Mexico's drug cartels, dies at 80

    Miguel Angel Felix Gallardo, a prominent figure in Mexican drug trafficking, died on Sunday at the age of 80. He was responsible for building modern drug networks and orchestrated the murder of DEA agent Enrique 'Kiki' Camarena. After his arrest in 1989, he served a long prison sentence but remained influential in popular culture. The Guadalajara cartel that he co-founded disintegrated in the 1990s, leading to new regional criminal organizations.

    Miguel Ángel Félix Gallardo, one of Mexico's most notorious drug lords who worked with Pablo Escobar and was convicted for the 1985 killing of US DEA agent Kiki Camarena, dies aged 80

    Miguel Ángel Félix Gallardo, known for founding a major drug cartel in Mexico, died in a hospital. He had been imprisoned since 1989 over drug trafficking and weapons charges. Gallardo was also convicted for the kidnapping and murder of a DEA agent, resulting in additional sentencing. While in prison, he suffered from varoious health issues but maintained his innocence.

    Fewer than 10 people, under a year old: Anthropic reportedly paid $400 million for this biotech AI startup; what does it do?

    In its October announcement, the company mentioned Claude for Life Sciences, which is a tool that aims to help scientific researchers make discoveries. But, the most interesting part of the story is not the deal or the numbers. It is that Coefficient Bio's team had less than 10 employees, and was set to join Anthropic's healthcare and life sciences group.

    18 patent applications for HIV drug lenacapavir may delay affordable generics in India

    Gilead Sciences has filed 18 patent applications in India for lenacapavir, raising concerns among patient groups. They argue these applications may hinder the availability of affordable generic versions of the HIV drug. Consumer advocates have approached the patent office, seeking a rejection of these filings as they may constitute evergreening. If granted, these patents could remain valid until 2042, extending exclusive rights.

    Compulsory licensing of drugs only after exhausting all other measures: Department of Pharmaceuticals secretary Manoj Joshi

    The government plans to address the high costs of innovative medicines by first negotiating prices. Compulsory licensing will be considered only after other alternatives are exhausted. Trade margins on high-cost drugs are being examined to enhance affordability. Discussions are ongoing with pharmaceutical companies to improve access and affordability of patented drugs. The government is also working on initiatives to support the local pharmaceutical manufacturing sector.

    CAG to audit urea subsidy, distribution in 169 districts

    India plans to spend ₹2.17 lakh crore on fertiliser subsidies this fiscal year, focusing on urea. The Comptroller and Auditor General will conduct a comprehensive audit examining 149 districts with high urea consumption. This audit will address efficiency, demand assessment, and subsidy rationalisation initiatives while ensuring environmental sustainability. It aims to scrutinise import planning and financial impacts related to urea production and subsidies.

    • NPPA issues strict guidelines for trade margin rationalisation on 137 cancer drugs to benefit patients

      The National Pharmaceutical Pricing Authority has implemented strict monitoring of Trade Margin Rationalisation for certain anti-cancer drugs. Compliance with revised prices has been mandated for manufacturers, retailers, and hospitals. They must display updated price lists to inform patients effectively. Complaints about overcharging or drug shortages can be reported through designated channels. State Drug Controllers have been instructed to submit compliance reports to ensure adherence by 16 November 2026.

      UAE: 14 killed, 30 injured after truck crashes into vehicles in Fujairah; Indians among hurt

      At least 14 people were killed and 30 injured, including Indian nationals, after a truck rammed into several vehicles on a road in the UAE's Fujairah emirate, triggering a fire. Fujairah Police said 15 injured people had been discharged from hospitals, while the remaining victims continued to receive treatment.

      The Trump administration has reported returning over $12 billion in oil revenue to Venezuela as of September 30. Almost all funds from oil sales have been directed to support infrastructure and humanitarian needs. The U.S. Treasury managed the escrow account from which these funds were disbursed following approved requests. Various payments were made for essential supplies and services, including healthcare-related equipment.

      Cancer Drugs: 1,000% Markups, Price Cuts & the Hospital Profit Puzzle
      India may open doors to multinational pharma firms for first-in-human Phase I trials

      India is considering modifications to its pharmaceutical regulatory framework to attract multinational companies for clinical trials. Discussions have commenced regarding allowing these companies to conduct Phase I trials in India. Authorities aim to enhance India's appeal for global drug innovation and development. Strengthening manufacturing compliance over the last two years has also been part of the plan.

      2,450 kg chicken destroyed: FDA finds food safety violations, including 700 kg meat brought from Delhi in thermocol boxes without temperature control for 36 hours

      Goa's Food and Drugs Administration has destroyed 2,450 kg of chicken during two inspections in South Goa after detecting food safety violations. Officials intercepted 700 kg of chicken transported from Delhi at Margao railway station after nearly 36 hours of transport without temperature control. Another 1,750 kg was destroyed over missing labels and purchase records at a Verna cold storage unit.

      GLP-1 drugs for weight loss Ozempic, Wegovy linked to vision loss: What is NAION, who is at risk and what symptoms should users watch for?

      Side effects of weight loss drugs: The makers of GLP-1 weight loss drugs such as Ozempic, Wegovy and Mounjaro must add a warning label about a possible link to permanent vision loss, the US Food and Drug Administration has said. Older age people, those suffering with diabetes, high blood pressure are at a higher risk. NAION typically causes sudden, painless vision loss, often affecting one eye.

      BDR Pharma to acquire Acme’s oral solid formulations business

      BDR Pharma will acquire a controlling stake in Acme Formulation’s oral solid formulations business from existing shareholders, led by private equity firm PAG. The deal will strengthen BDR’s contract development and manufacturing (CDMO) platform by adding capabilities in thyroid, women’s healthcare and general medicines.

      India, US vow to jointly act against emerging drug threats

      India and the US have agreed to strengthen cooperation against emerging narcotics threats, including illicit drug trafficking and the diversion of synthetic drugs and chemical precursors. At a bilateral meeting in New Delhi, both sides discussed intelligence sharing, coordinated enforcement, precursor control, pharmaceutical supply chains and measures to reduce drug demand.

      Who is Thomas Massie and why has he proposed impeachment proceedings against US Defence Secretary Pete Hegseth?

      Thomas Massie has proposed eight articles of impeachment against US Defence Secretary Pete Hegseth. The congressman from Kentucky has accused the Defence Secretary of operating military operations without congressional approval. Other elements of concern are the protection of civilians, revenge against a senator and military operations in Yemen and Venezuela. A vote could be held in the House within two legislative days.

      Over 1,300 anti-cancer drugs to get cheaper

      India's National Pharmaceutical Pricing Authority is set to cap trade margins on anti-cancer drugs starting November 2026. The initiative aims to save around ₹2,500 crore annually for cancer patients. The list includes 1,366 drug brands, with substantial price reductions for several high-cost medications. However, some patented drugs will maintain their prices despite the changes. Patients and medical institutions are directed to display revised prices prominently.

      Home Minister Amit Shah sets December 2028 drug-free Gujarat target, a year ahead of national deadline

      Union Home Minister Amit Shah on Monday set December 31, 2028, as the deadline to make Gujarat drug-free, a year ahead of India’s December 31, 2029, target. Addressing a gathering in Ahmedabad, he urged citizens to report drug abuse and drug sales to authorities, stressing that government efforts alone cannot eliminate narcotics.

      Cancer drug prices revised from today; patients may save Rs 3,540 crore annually

      The government has revised the prices of 1,364 anti-cancer medicine formulations effective from November 9. This decision aims to limit trade margins and reduce consumer costs for cancer drugs. According to official reports, this measure is expected to save consumers Rs 3,540.38 crore each year.

      Cancer drug prices to fall by up to 96% from November 9; consumers set to save Rs 3,502 crore annually

      Starting November 9, consumers in India will benefit from significantly reduced prices on 137 anti-cancer drugs. The government has capped trade margins on these medications, leading to an estimated annual savings of Rs 3,502.31 crore for consumers. Price reductions have been reported across 1,225 formulations, with some reductions exceeding 50 percent.

      Pharma industry steps up API investments to cut import dependence, move up value chain

      India's pharmaceutical sector is shifting towards high-value medicines and reducing reliance on imports through local manufacturing. Investments in active pharmaceutical ingredients and advanced therapies are on the rise to meet new healthcare demands. Industry leaders highlight the significance of supply-chain resilience and advancements in manufacturing capabilities. Recent data indicates strong domestic market growth and increasing pharmaceutical exports.

      Hegseth vows to fight impeachment as Democrats target US defense chief after midterm losses

      US Defense Secretary Pete Hegseth has vowed to resist impeachment efforts following recent congressional elections. After Republican losses, his handling of the Iran war faces scrutiny from lawmakers. President Donald Trump continues to express support for Hegseth despite rising opposition within Congress. Hegseth has defended military policies, claiming they are essential for national security and military funding. The newly formed Democratic majority intends to investigate Hegseth's tenure extensively.

      India, Israel vote against Pak-backed UN arms control resolution: Sources dismiss voting coordination

      India has voiced its opposition to a Pakistan-led UN resolution on regional arms control, asserting that arms control transcends regional boundaries. With approximately 180 nations endorsing it, both India and Israel stood alone in dissent. India reiterated its long-standing position on arms control as a matter of principle, while a few other countries, including the U.S., shared hesitations about the resolution.

      Centre proposes 10 new entry points for drug imports into India, Noida airport included

      The Centre has proposed expanding India's authorised import network for pharmaceuticals and medical devices by adding ten new locations. These include Noida International Airport and several inland container depots across industrial hubs in India. This expansion aims to simplify the import process and reduce transportation costs for companies. The health ministry has invited public feedback on the draft amendment to Drugs Rules, 1945.

      Dr Reddy's Laboratories receives ANVISA approval for generic semaglutide injection in Brazil

      Dr Reddy’s Laboratories obtained marketing authorisation from Brazil’s ANVISA for a generic semaglutide injection. The product will be available as a pre-filled, multi-dose pen in two dosages for weekly administration. This drug targets treatment for type 2 diabetes alongside diet and exercise, particularly in patient groups needing alternative therapies. Brazil's diabetes prevalence creates significant market demand, estimated at approximately $244.6 million.

      Punjab: Rahul Gandhi targets CM Bhagwant Mann over 'Nasha', says AAP govt run from Delhi

      Rahul Gandhi launched the Congress campaign in Sangrur, criticizing Chief Minister Bhagwant Mann's handling of addiction issues. He claimed that Mann's alleged alcohol use undermines efforts to combat substance abuse in Punjab. Gandhi accused AAP leader Arvind Kejriwal of controlling the Punjab government from Delhi, asserting that the state needs local leadership. He also challenged Union Home Minister Amit Shah's promises regarding drug eradication by 2029.

      ‘Punjab’s remote control is in Delhi’: Rahul Gandhi attacks AAP, Bhagwant Mann over drugs; challenges PM for an open debate

      Rahul Gandhi held an 'Insaaf Rally' in Sangrur, where he criticized the Aam Aadmi Party's governance in Punjab. He questioned Chief Minister Bhagwant Mann's effectiveness in combating drug abuse, emphasizing that Punjab needs a state-focused government. Gandhi recalled his concern for slain singer Sidhu Moose Wala, highlighting the threats faced by talented individuals in the state.

      Wockhardt seeks 14-year data shield for India-made drugs

      Mumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for difficult-to-treat infections. In May this year, the company secured approvals from Indian and US drug regulators for a breakthrough drug, Zaynich (cefepime + zidebactam), to treat complicated urinary tract infection, including acute pyelonephritis or severe kidney infections. Wockhardt has showcased six drugs to treat antimicrobial resistance (AMR).

      High Court restrains NPPA from action against AstraZeneca

      The Delhi High Court has issued a temporary restraining order against the NPPA's actions toward AstraZeneca Pharma. This order remains in effect until the next hearing date, January 11. AstraZeneca has argued that its product may not fall under controlled drug prices. The NPPA has accused AstraZeneca of overcharging for the inhaler from May 2016 to November 2025. AstraZeneca denies these allegations and claims compliance with the price regulations.

      Load More
    The Economic Times
    BACK TO TOP